suggest vaccines provide protection new variants clinical trial data antibody neutralization studies vaccines designed original strains virus not effective certain new variants particularly mutations found b.1.351 variant widespread south africa new variants changes spike protein virus uses infect cells little bit different vaccinated person body seen vaccine overall vaccines authorized u.s. meeting efficacy targets protection new variants best way prevent new variants emerging getting lots people vaccinated moderna developing booster shot offer additional protection needed pfizer biontech mrna vaccine ones pfizer biontech moderna provides genetic instructions making viral proteins form single stranded rna lipid coat cells injecting virus exciting advantages